|
US4192946A
(en)
|
1978-06-29 |
1980-03-11 |
Ciba-Geigy Corporation |
Process for producing 3-hydroxy-5-halopyridines
|
|
DE3148651A1
(de)
|
1981-12-09 |
1983-07-21 |
Henkel Kgaa |
"haarfaerbemittel, enthaltend 5-halo-2,3-pyridindiole als kupplerkomponente"
|
|
US4582823A
(en)
|
1984-08-15 |
1986-04-15 |
Warner-Lambert Company |
Method for treating schizophrenia and medicaments therefor
|
|
WO1989000158A1
(en)
|
1987-07-02 |
1989-01-12 |
Pfizer Inc. |
Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
|
|
IT1226727B
(it)
|
1988-07-29 |
1991-02-05 |
Simes |
Farmaci precursori della dopamina.
|
|
US4922901A
(en)
|
1988-09-08 |
1990-05-08 |
R. J. Reynolds Tobacco Company |
Drug delivery articles utilizing electrical energy
|
|
DE69016688T2
(de)
|
1989-04-20 |
1995-10-05 |
Zambon Spa |
Dopamin-Medikament-Vorstufe.
|
|
US5187166A
(en)
|
1990-07-31 |
1993-02-16 |
Nisshin Flour Milling Co., Ltd. |
Azabicyclo derivatives and their use as antiemetics
|
|
WO1992012122A1
(en)
|
1990-12-27 |
1992-07-23 |
Abbott Laboratories |
N-protected aminoalkylaldehydes
|
|
DE69213559T2
(de)
|
1991-05-30 |
1997-02-27 |
Mitsui Toatsu Chemicals |
Tetravinylpyrazine-Verbindung, Verfahren zur Herstellung derselben und elektrolumineszentes Element und damit hergesteller nichtlinearer optischer Stoff
|
|
US5212188A
(en)
|
1992-03-02 |
1993-05-18 |
R. J. Reynolds Tabacco Company |
Method for treatment of neurodegenerative diseases
|
|
IL107184A
(en)
|
1992-10-09 |
1997-08-14 |
Abbott Lab |
Heterocyclic ether compounds that enhance cognitive function
|
|
US5852041A
(en)
|
1993-04-07 |
1998-12-22 |
Sibia Neurosciences, Inc. |
Substituted pyridines useful as modulators of acethylcholine receptors
|
|
US5493026A
(en)
|
1993-10-25 |
1996-02-20 |
Organix, Inc. |
Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders
|
|
IT1274018B
(it)
|
1994-02-23 |
1997-07-14 |
Riace Ets |
Derivati del 3,8-diazabiciclo(3.2.1.)ottano ad attivita' analgesica
|
|
DK0765320T3
(da)
|
1994-06-14 |
2001-11-26 |
Pfizer |
Benzimidazolonderivater med central dopaminerg aktivitet
|
|
GB2295387A
(en)
|
1994-11-23 |
1996-05-29 |
Glaxo Inc |
Quinazoline antagonists of alpha 1c adrenergic receptors
|
|
US5616707A
(en)
|
1995-01-06 |
1997-04-01 |
Crooks; Peter A. |
Compounds which are useful for prevention and treatment of central nervous system disorders
|
|
US5597919A
(en)
|
1995-01-06 |
1997-01-28 |
Dull; Gary M. |
Pyrimidinyl or Pyridinyl alkenyl amine compounds
|
|
US5604231A
(en)
|
1995-01-06 |
1997-02-18 |
Smith; Carr J. |
Pharmaceutical compositions for prevention and treatment of ulcerative colitis
|
|
US5585388A
(en)
|
1995-04-07 |
1996-12-17 |
Sibia Neurosciences, Inc. |
Substituted pyridines useful as modulators of acetylcholine receptors
|
|
US5583140A
(en)
|
1995-05-17 |
1996-12-10 |
Bencherif; Merouane |
Pharmaceutical compositions for the treatment of central nervous system disorders
|
|
IL118279A
(en)
|
1995-06-07 |
2006-10-05 |
Abbott Lab |
Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
|
|
US5616716A
(en)
|
1996-01-06 |
1997-04-01 |
Dull; Gary M. |
(3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
|
|
AT403803B
(de)
|
1996-04-19 |
1998-05-25 |
Sanochemia Ltd |
Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
|
|
US20020052497A1
(en)
|
2000-03-09 |
2002-05-02 |
Targacept, Inc. |
Compounds capable of activating cholinergic receptors
|
|
JP4357001B2
(ja)
|
1996-04-23 |
2009-11-04 |
ターガセプト，インコーポレイテッド |
中枢神経系障害の予防及び治療のための医薬組成物
|
|
US5663356A
(en)
|
1996-04-23 |
1997-09-02 |
Ruecroft; Graham |
Method for preparation of aryl substituted alefinic secondary amino compounds
|
|
US6979695B2
(en)
|
1996-04-23 |
2005-12-27 |
Targacept, Inc. |
Compounds capable of activating cholinergic receptors
|
|
US5726189A
(en)
|
1996-05-03 |
1998-03-10 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Method for imaging nicotinic acetylcholinergic receptors in the brain using radiolabeled pyridyl-7-azabicyclo 2.2.1!heptanes
|
|
US5811442A
(en)
|
1997-02-21 |
1998-09-22 |
Bencherif; Merouane |
Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow
|
|
US5861423A
(en)
|
1997-02-21 |
1999-01-19 |
Caldwell; William Scott |
Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
|
|
PT983249E
(pt)
|
1997-05-08 |
2002-08-30 |
Pfizer Prod Inc |
Procesos e intermediarios para a preparacao de derivados de indazole substituidos
|
|
ATE491689T1
(de)
|
1997-10-27 |
2011-01-15 |
Neurosearch As |
Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
|
|
US6632823B1
(en)
|
1997-12-22 |
2003-10-14 |
Merck & Co., Inc. |
Substituted pyridine compounds useful as modulators of acetylcholine receptors
|
|
US6232316B1
(en)
|
1998-06-16 |
2001-05-15 |
Targacept, Inc. |
Methods for treatment of CNS disorders
|
|
CA2677519A1
(en)
|
1998-06-16 |
1999-12-23 |
Targacept, Inc. |
Aryl substituted olefinic amines and their use as cholinergic receptors agonists
|
|
US6218383B1
(en)
|
1998-08-07 |
2001-04-17 |
Targacept, Inc. |
Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
|
|
US6337351B1
(en)
|
1998-10-22 |
2002-01-08 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
US6953855B2
(en)
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
|
FR2788982B1
(fr)
|
1999-02-02 |
2002-08-02 |
Synthelabo |
Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
|
|
JP2003501416A
(ja)
|
1999-06-07 |
2003-01-14 |
ターガセプト，インコーポレイテッド |
医薬組成物およびその使用法
|
|
GB9922271D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Formulation
|
|
US6506769B2
(en)
|
1999-10-06 |
2003-01-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
|
AU2001252350A1
(en)
|
2000-04-13 |
2001-10-30 |
Innovata Biomed Limited |
Medicaments for treating respiratory disorders comprising formoterol and fluticasone
|
|
US6743812B1
(en)
|
2000-07-14 |
2004-06-01 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
US6432954B1
(en)
|
2000-07-14 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
DE60222396T2
(de)
|
2001-03-29 |
2008-05-15 |
Eli Lilly And Co., Indianapolis |
N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste
|
|
GB2381750A
(en)
|
2001-10-10 |
2003-05-14 |
Inspire Pharmaceuticals Inc |
Treatment for enhancing joint lubrication
|
|
EP1463481A4
(en)
|
2001-12-14 |
2008-06-25 |
Targacept Inc |
METHOD AND COMPOSITIONS FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM
|
|
AU2003226094A1
(en)
|
2002-03-27 |
2003-10-13 |
Smithkline Beecham Corporation |
Compounds and methods
|
|
US20040044023A1
(en)
|
2002-08-30 |
2004-03-04 |
Marc Cantillon |
Compositions and methods for treating or preventing memory impairment
|
|
US20050203130A1
(en)
|
2003-12-02 |
2005-09-15 |
Erik Buntinx |
Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
|
|
WO2005063296A2
(en)
|
2003-12-23 |
2005-07-14 |
Pfizer Products Inc. |
Therapeutic combination for cognition enhancement and psychotic disorders
|
|
US20050171088A1
(en)
|
2004-01-30 |
2005-08-04 |
Astrazeneca Ab |
Treatment of psychoses with dibenzothiazepine antipsychotic
|
|
WO2005105729A1
(en)
|
2004-02-13 |
2005-11-10 |
Mediquest Therapeutics, Inc. |
Polyamine analogs that activate antizyme frameshifting
|
|
US7537590B2
(en)
|
2004-07-30 |
2009-05-26 |
Microchips, Inc. |
Multi-reservoir device for transdermal drug delivery and sensing
|
|
JP4148199B2
(ja)
|
2004-07-30 |
2008-09-10 |
松下電工株式会社 |
電気かみそり
|
|
JP5254616B2
(ja)
|
2004-09-13 |
2013-08-07 |
クロノ セラピューティクス、インコーポレイテッド |
生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
|
|
UA88792C2
(ru)
*
|
2004-11-10 |
2009-11-25 |
Таргасепт, Інк. |
Гидроксибензоатные соли метаникотиновых соединений
|
|
US7459469B2
(en)
*
|
2004-11-10 |
2008-12-02 |
Targacept, Inc. |
Hydroxybenzoate salts of metanicotine compounds
|
|
TWI389889B
(zh)
|
2006-05-09 |
2013-03-21 |
Targacept Inc |
（２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
|
|
US8017785B2
(en)
|
2006-05-09 |
2011-09-13 |
Astrazeneca Ab |
Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-penten 2-amine
|
|
US20080138416A1
(en)
|
2006-06-13 |
2008-06-12 |
Fmc Biopolymer As |
Method and systems for using biopolymer-based beads and hydrogels
|
|
US20080085888A1
(en)
|
2006-09-15 |
2008-04-10 |
Breining Scott R |
Therapeutic Combinations
|
|
US20080167286A1
(en)
|
2006-12-12 |
2008-07-10 |
Abbott Laboratories |
Pharmaceutical compositions and their methods of use
|
|
WO2008091592A1
(en)
|
2007-01-22 |
2008-07-31 |
Targacept, Inc. |
Intranasal, buccal, and sublingual administration of metanicotine analogs
|